PCa risk was analysed using Cox proportional hazard models for albumin, CRP, haptoglobin and white blood cells at the third time point, adjusting for age, socioeconomic status, education level, Charlson comorbidity index (CCI) and cancer history, and risk signature analysis with training and validation sets (preventing overfitting) including repeated biomarker measurements, covariate interactions and baseline factors. This evidence concerns the gene CRP and cancer.